Carcinoma of unknown primary · 17 regimens
Cost vs Efficacy · 11 points
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Erlotinib and Bevacizumab Variant #01 | — | R 26 036 | 28d | ~16.4 mo | ~49.1 mo | ~52 | ~R 1 353 852 PFS proxy · indirect | 7 |
GCP Variant #01 | — | R 20 979 | 21d | ~16.0 mo | ~50.9 mo | ~6 | ~R 125 876 PFS proxy · indirect | 3 |
Docetaxel and Gemcitabine Variant #01 | — | R 6 266 | 21d | ~6.2 mo | ~26.9 mo | ~9 | ~R 56 391 PFS proxy · indirect | 3 |
Carboplatin and Gemcitabine (GCb) and Paclitaxel Variant #01 | — | R 6 151 | 21d | — | ~10.8 mo | ~7 | ~R 43 055 PFS proxy · indirect | 1 |
Carboplatin and Docetaxel (DCb) Variant #06 | — | R 5 501 | 21d | ~4.7 mo | ~22.3 mo | ~6 | ~R 33 004 PFS proxy · indirect | 4 |
Gemcitabine and Irinotecan Variant #01 | — | R 5 155 | 21d | — | — | ~6 | ~R 30 929 indirect | — |
Carboplatin and Gemcitabine (GCb) Variant #01 | — | R 4 414 | 21d | ~6.3 mo | ~12.1 mo | ~2 | ~R 8 829 PFS proxy · indirect | 38 |
Cisplatin and Gemcitabine (GC) Variant #01 | — | R 3 933 | 21d | ~6.9 mo | ~11.9 mo | ~6 | ~R 23 595 PFS proxy · indirect | 59 |
PCE Variant #01 | — | R 3 876 | 21d | — | — | ~9 | ~R 34 882 indirect | — |
DCF Variant #01 | — | R 3 508 | 21d | ~12.8 mo | ~18.8 mo | ~2 | ~R 7 015 PFS proxy · indirect | 10 |
Cisplatin and Docetaxel (DC) Variant #05 | — | R 3 185 | 21d | ~5.2 mo | ~13.0 mo | ~3 | ~R 9 556 PFS proxy · indirect | 11 |
BEP Variant #01 Partial | — | R 2 787 | 21d | — | — | ~3 | ~R 8 361 indirect | — |
PCF Variant #01 | — | R 2 300 | — | — | — | ~3 | ~R 6 899 indirect | — |
Cisplatin and Irinotecan (IC) Variant #01 | — | R 1 795 | 21d | ~3.8 mo | ~12.9 mo | ~2 | ~R 3 591 PFS proxy · indirect | 10 |
Carboplatin and Paclitaxel (CP) Variant #02 | — | R 1 025 | 21d | ~8.9 mo | ~13.3 mo | ~12 | ~R 12 296 PFS proxy · indirect | 114 |
Cisplatin monotherapy Variant #01 | — | R 588 | 21d | ~2.1 mo | ~8.7 mo | ~6 | ~R 3 530 PFS proxy · indirect | 8 |
Nivolumab monotherapy Variant #01 Partial | — | — | 14d | ~4.6 mo | ~12.2 mo | ~2 | — | 28 |
17 of 17 regimens shown